Open-Label Extension of RIDE and RISE Shows Improved Visual Outcomes Maintained without Ranibizumab Retreatment

Article Information

DOI 
http://dx.doi.org/10.1177/155989771443002
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2014 MD Conference Express®

Author Information

  1. Nicola Parry
  1. Charles C. Wykoff, MD, PhD
    1. Retina Consultants of Houston, Houston, Texas, USA
View Full Text

Article usage

AbstractFullPDF
Apr 2015600
Jun 2015922
Jul 2015400
Aug 20151622
Sep 201511000
Oct 2015433
Nov 20154310
Total19287

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Open-Label Extension of RIDE and RISE Shows Improved Visual Outcomes Maintained without Ranibizumab Retreatment
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Diabetes Mellitus
Ophthalmology Clinical Trials
Retinal Diseases
Ophthalmology
Diabetes Mellitus
Ophthalmology Clinical Trials
Retinal Diseases